Correlation Between Shenzhen Bioeasy and Hygon Information

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and Hygon Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and Hygon Information into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and Hygon Information Technology, you can compare the effects of market volatilities on Shenzhen Bioeasy and Hygon Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of Hygon Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and Hygon Information.

Diversification Opportunities for Shenzhen Bioeasy and Hygon Information

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shenzhen and Hygon is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and Hygon Information Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hygon Information and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with Hygon Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hygon Information has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and Hygon Information go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and Hygon Information

Assuming the 90 days trading horizon Shenzhen Bioeasy is expected to generate 1.13 times less return on investment than Hygon Information. But when comparing it to its historical volatility, Shenzhen Bioeasy Biotechnology is 1.01 times less risky than Hygon Information. It trades about 0.17 of its potential returns per unit of risk. Hygon Information Technology is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  7,473  in Hygon Information Technology on September 18, 2024 and sell it today you would earn a total of  4,869  from holding Hygon Information Technology or generate 65.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shenzhen Bioeasy Biotechnology  vs.  Hygon Information Technology

 Performance 
       Timeline  
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.
Hygon Information 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Hygon Information Technology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hygon Information sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Bioeasy and Hygon Information Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Bioeasy and Hygon Information

The main advantage of trading using opposite Shenzhen Bioeasy and Hygon Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, Hygon Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hygon Information will offset losses from the drop in Hygon Information's long position.
The idea behind Shenzhen Bioeasy Biotechnology and Hygon Information Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance